Receptors, Vasoactive Intestinal Polypeptide, Type I
"Receptors, Vasoactive Intestinal Polypeptide, Type I" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pituitary adenylate cyclase-activating polypeptide receptor subtype that binds both PACAP and VASOACTIVE INTESTINAL PEPTIDE. It is found predominately in the BRAIN.
| Descriptor ID |
D051238
|
| MeSH Number(s) |
D12.776.543.750.695.665.760 D12.776.543.750.695.900.520
|
| Concept/Terms |
Receptors, Vasoactive Intestinal Polypeptide, Type I- Receptors, Vasoactive Intestinal Polypeptide, Type I
- VIP1 Receptor
- VIP1 Receptors
- Receptors, VIP1
- VPAC1 Receptor
- Receptor, VPAC1
- Receptor, VIP1
- Vasoactive Intestinal Peptide 1 Receptor
- PACAP Type II Receptor
- PACAPR-2 Protein
- PACAPR 2 Protein
- VIPR1 Protein
- Vasoactive Intestinal Peptide Receptor 1
- Pituitary Adenylate Cyclase-Activating Peptide Receptor Type II
- Pituitary Adenylate Cyclase Activating Peptide Receptor Type II
- PACAP Receptors, Type II
- VIP Receptors, Type I
- Vasoactive Intestinal Peptide Receptors, Type I
- Receptors, Pituitary Adenylate Cyclase-Activating Peptide, Type II
- VIP 1 Receptor
- Receptor, VIP 1
- VIP-1 Receptor
- Receptor, VIP-1
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Vasoactive Intestinal Polypeptide, Type I".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide [D12.776.543.750.695.665]
- Receptors, Vasoactive Intestinal Polypeptide, Type I [D12.776.543.750.695.665.760]
- Receptors, Vasoactive Intestinal Peptide [D12.776.543.750.695.900]
- Receptors, Vasoactive Intestinal Polypeptide, Type I [D12.776.543.750.695.900.520]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Vasoactive Intestinal Polypeptide, Type I".
This graph shows the total number of publications written about "Receptors, Vasoactive Intestinal Polypeptide, Type I" by people in this website by year, and whether "Receptors, Vasoactive Intestinal Polypeptide, Type I" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Vasoactive Intestinal Polypeptide, Type I" by people in Profiles.
-
Tripathi SK, Kean R, Bongiorno E, Hooper DC, Jin YY, Wickstrom E, McCue PA, Thakur ML. Targeting VPAC1 Receptors for Imaging Glioblastoma. Mol Imaging Biol. 2020 04; 22(2):293-302.
-
Tripathi SK, Kumar P, Trabulsi EJ, Kim S, McCue PA, Intenzo C, Berger A, Gomella L, Thakur ML. VPAC1 Targeted 64Cu-TP3805 kit preparation and its evaluation. Nucl Med Biol. 2017 Aug; 51:55-61.
-
Tripathi S, Trabulsi EJ, Gomella L, Kim S, McCue P, Intenzo C, Birbe R, Gandhe A, Kumar P, Thakur M. VPAC1 Targeted (64)Cu-TP3805 Positron Emission Tomography Imaging of Prostate Cancer: Preliminary Evaluation in Man. Urology. 2016 Feb; 88:111-8.
-
Thakur ML, Zhang K, Berger A, Cavanaugh B, Kim S, Channappa C, Frangos AJ, Wickstrom E, Intenzo CM. VPAC1 receptors for imaging breast cancer: a feasibility study. J Nucl Med. 2013 Jul; 54(7):1019-25.
-
Thakur ML, Devadhas D, Zhang K, Pestell RG, Wang C, McCue P, Wickstrom E. Imaging spontaneous MMTVneu transgenic murine mammary tumors: targeting metabolic activity versus genetic products. J Nucl Med. 2010 Jan; 51(1):106-11.
-
Zhang K, Aruva MR, Shanthly N, Cardi CA, Rattan S, Patel C, Kim C, McCue PA, Wickstrom E, Thakur ML. PET imaging of VPAC1 expression in experimental and spontaneous prostate cancer. J Nucl Med. 2008 Jan; 49(1):112-21.
-
Thakur ML, Aruva MR, Gariepy J, Acton P, Rattan S, Prasad S, Wickstrom E, Alavi A. PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog. J Nucl Med. 2004 Aug; 45(8):1381-9.